Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay
Authors
Keywords
-
Journal
Nature Protocols
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-09-26
DOI
10.1038/s41596-020-0394-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China
- (2020) Aiping Wu et al. Cell Host & Microbe
- Emerging coronaviruses: Genome structure, replication, and pathogenesis
- (2020) Yu Chen et al. JOURNAL OF MEDICAL VIROLOGY
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
- (2020) Jasper Fuk-Woo Chan et al. Emerging Microbes & Infections
- The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
- (2020) Nature Microbiology
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
- (2020) Wanbo Tai et al. Cellular & Molecular Immunology
- Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals
- (2020) Ling Ni et al. IMMUNITY
- Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
- (2020) Feng-Cai Zhu et al. LANCET
- Human neutralizing antibodies elicited by SARS-CoV-2 infection
- (2020) Bin Ju et al. NATURE
- A serological assay to detect SARS-CoV-2 seroconversion in humans
- (2020) Fatima Amanat et al. NATURE MEDICINE
- Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells
- (2020) Shutoku Matsuyama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
- (2020) Katharine H. D. Crawford et al. Viruses-Basel
- Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
- (2020) Xiuyuan Ou et al. Nature Communications
- Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells
- (2020) Yunlong Cao et al. CELL
- A tool with many applications: vesicular stomatitis virus in research and medicine
- (2020) Altar M. Munis et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Genetic evolution analysis of 2019 novel coronavirus and coronavirus from other species
- (2020) Chun Li et al. INFECTION GENETICS AND EVOLUTION
- Vaccine development and therapeutic design for 2019‐nCoV/SARS‐CoV‐2: Challenges and chances
- (2020) Mahnaz Ghaebi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Vaccines against Coronaviruses: The State of the Art
- (2020) Cristiano Conte et al. Vaccines
- High SARS-CoV-2 antibody prevalence among healthcare workers exposed to COVID-19 patients
- (2020) Yuxin Chen et al. JOURNAL OF INFECTION
- Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain
- (2019) Yusen Zhou et al. Viruses-Basel
- A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
- (2019) Shuai Xia et al. Science Advances
- In vitro and in vivo efficacy of a Rift Valley fever virus vaccine based on pseudovirus
- (2019) Jian Ma et al. Human Vaccines & Immunotherapeutics
- Development of Middle East Respiratory Syndrome Coronavirus vaccines – advances and challenges
- (2017) Heeyoun Cho et al. Human Vaccines & Immunotherapeutics
- MERS-CoV spike protein: a key target for antivirals
- (2016) Lanying Du et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Quantification of Lyssavirus-Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudotype Particles
- (2016) Sarah Moeschler et al. Viruses-Basel
- Structure, Function, and Evolution of Coronavirus Spike Proteins
- (2016) Fang Li Annual Review of Virology
- Single-Cell and Single-Cycle Analysis of HIV-1 Replication
- (2015) Mowgli Holmes et al. PLoS Pathogens
- Generation of VSV pseudotypes using recombinant ΔG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines
- (2010) Michael A. Whitt JOURNAL OF VIROLOGICAL METHODS
- Rho GTPases Modulate Entry of Ebola Virus and Vesicular Stomatitis Virus Pseudotyped Vectors
- (2009) K. Quinn et al. JOURNAL OF VIROLOGY
- The spike protein of SARS-CoV — a target for vaccine and therapeutic development
- (2009) Lanying Du et al. NATURE REVIEWS MICROBIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started